|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
4.580 USD |
-2.97% |
|
-5.37% | -64.96% |
Published on 10/07/2025
at 04:43 pm EDT
Reuters
© Reuters – 2025
|
Owens & Minor to Divest Medical Supply Distribution Platform to Platinum Equity |
Oct. 07 |
MT |
|
Platinum Equity to acquire products & healthcare services business from Owens & Minor |
Oct. 07 |
RE |
|
Owens & Minor announces agreement to divest Products & Healthcare Services segment to Platinum Equity for $375mm |
Oct. 07 |
RE |
|
Platinum Equity, LLC an Equity Purchase Agreement to acquire O&M PHS LLC from Owens & Minor, Inc. for approximately $380 million. |
Oct. 06 |
CI |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from S&P 1000 |
Sep. 21 |
CI |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from S&P 600 |
Sep. 21 |
CI |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from S&P Composite 1500 |
Sep. 21 |
CI |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from S&P 600 Health Care |
Sep. 21 |
CI |
|
Owens & Minor, Inc. Announces Resignation of Snehashish Sarkar as Executive Vice President and Chief Information Officer, Effective September 26, 2025 |
Sep. 19 |
CI |
|
Uber to Replace Charter Communications in S&P 100; AppLovin, Robinhood, Emcor to Join S&P 500 |
Sep. 08 |
MT |
|
Applovin, Robinhood Markets and Emcor Group set to join S&P 500; others to join S&P 100, S&P MidCap 400 and S&P SmallCap 600 |
Sep. 05 |
RE |
|
UBS Adjusts Price Target on Owens & Minor to $7 From $13, Maintains Buy Rating |
Aug. 13 |
MT |
|
Tranche Update on Owens & Minor, Inc.’s Equity Buyback Plan announced on February 28, 2025. |
Aug. 11 |
CI |
|
Top Midday Decliners |
Aug. 11 |
MT |
|
Sector Update: Health Care Stocks Edge Higher Monday Afternoon |
Aug. 11 |
MT |
|
Owens & Minor Shares Fall After Q2 Adjusted Earnings, 2025 Outlook Miss Expectations |
Aug. 11 |
MT |
|
Owens & Minor, Inc., Q2 2025 Earnings Call, Aug 11, 2025 |
Aug. 11 |
|
|
Owens & Minor Seeks Acquisitions |
Aug. 11 |
CI |
|
Owens & Minor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 |
Aug. 11 |
CI |
|
Owens & Minor misses Q2 revenue, adjusted EPS expectations |
Aug. 11 |
RE |
|
Owens & Minor Shares Rise After Upgrade From Baird |
Aug. 08 |
MT |
|
Baird Upgrades Owens & Minor to Outperform From Neutral, Price Target is $10 |
Aug. 08 |
MT |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from Russell 3000E Growth Index |
Jun. 30 |
CI |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from Russell 2500 Growth Index |
Jun. 30 |
CI |
|
Owens & Minor, Inc.(NYSE:OMI) dropped from Russell 2000 Growth Index |
Jun. 30 |
CI |
OMI: Dynamic Chart
Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own proprietary products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. It also offers a variety of programs providing outsourced logistics and marketing solutions to its suppliers as well. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and a provider of integrated home healthcare equipment and related services.
More about the company
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Buy
Average target price
6.600USD
Spread / Average Target
+44.10%
Consensus
Select your edition
All financial news and data tailored to specific country editions
link